デフォルト表紙
市場調査レポート
商品コード
1495406

固形臓器移植の拒絶反応市場:提供品目別、臓器タイプ別、拒絶反応タイプ別、エンドユーザー別-2024-2030年の世界予測

Solid Organ Transplantation Rejection Market by Offering (Diagnosis & Testing Solutions, Medications), Organ Type (Heart, Kidneys, Liver), Rejection Type, End-User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 181 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
固形臓器移植の拒絶反応市場:提供品目別、臓器タイプ別、拒絶反応タイプ別、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

固形臓器移植の拒絶反応市場規模は、2023年に77億9,000万米ドルと推定され、2024年には81億5,000万米ドルに達し、CAGR 4.90%で2030年には108億9,000万米ドルに達すると予測されます。

固形臓器移植は、肺、心臓、腎臓、肝臓などの重要な臓器の置換を含み、患者の生存率と生活の質を著しく向上させる。固形臓器移植の拒絶反応は、レシピエントの免疫系が移植臓器を異物と認識し、移植臓器にダメージを与えるプロセスであり、固形臓器移植の拒絶反応による薬物療法や治療が必要となります。慢性疾患、加齢、生活習慣などが主な原因で、臓器不全に苦しむ人の数は世界的に増加しています。臓器移植の需要が増加するにつれて、効果的な拒絶反応管理ソリューションへの要求も高まっています。このような臓器移植の増加は、市場の成長を促進します。さらに、固形臓器移植の進歩や拒絶反応管理技術の向上に対する一般市民や専門家の意識の高まりも、市場成長に大きく寄与しています。しかし、固形臓器移植には、移植前のスクリーニング、手術そのもの、術後のケア、継続的な免疫抑制治療など、複雑で費用のかかる医療処置が含まれるため、高額な費用が必要となり、特に経済的に発展していない地域では、患者にとって移植へのアクセスが制限され、ヘルスケア予算が圧迫される可能性があるため、市場成長の大きな障壁となり得る。現在進行中の改良型免疫抑制治療法の開拓は、移植後の臓器拒絶反応の発生率を低下させることにより、市場拡大の機会を提供するものです。

主な市場の統計
基準年[2023] 77億9,000万米ドル
予測年[2024] 81億5,000万米ドル
予測年 [2030] 108億9,000万米ドル
CAGR(%) 4.90%

地域別の洞察

南北アメリカ、特に米国では、高度な医療施設と整備されたヘルスケアシステムにより、臓器移植の普及率が高いです。この地域は強固な臓器移植ネットワークを有し、相当数の移植手術が行われているため、抗拒絶反応薬や治療薬に対するニーズが高いです。これらの製品は、移植臓器に対する免疫反応を抑えるために不可欠です。米国はまた、規制当局の強力なサポートと多額のヘルスケア支出により、新しい先進的な治療法の採用でリードしています。アジア太平洋地域は、固形臓器移植拒絶反応市場の成長を示しています。これは、ヘルスケア・インフラの増加、治療費の低下による医療ツーリズムの増加、慢性疾患に対する有効な選択肢としての移植に対する意識の高まりに後押しされています。インドや中国を含む国々では、移植件数が増加しています。EMEA地域の固形臓器移植拒絶反応介入市場は、臓器移植手術の増加と移植拒絶反応に対する意識の高まりにより、著しい成長を示しています。欧州には確立されたヘルスケアシステムがあり、規制の枠組みも整っています。中東およびアフリカは、ヘルスケアインフラの改善や移植プログラムの国際的な協力関係の影響を受け、緩やかな成長を遂げています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、固形臓器移植の拒絶反応市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront(F)、Pathfinder(P)、Niche(N)、Vital(V)に分類されます。

市場シェア分析

市場シェア分析は、固形臓器移植の拒絶反応市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、固形臓器移植の拒絶反応市場における現在の地位を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で臓器移植件数が増加
      • 移植と拒絶反応管理の進歩に関する認識の高まり
    • 抑制要因
      • 移植手術に伴う高額な費用
    • 機会
      • 免疫抑制治療とモニタリング技術の進歩
      • 拒絶反応リスクの正確な予測を向上させる遺伝子検査の出現
    • 課題
      • 免疫抑制療法に伴う複雑さ
  • 市場セグメンテーション分析
    • 提供内容:移植臓器の拒絶反応を治療するための薬剤の必要性が増加
    • エンドユーザー:病院での管理に広く使用されている固形臓器移植の拒絶反応
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 固形臓器移植の拒絶反応市場:提供別

  • 診断およびテストソリューション
  • 医薬品

第7章 固形臓器移植の拒絶反応市場臓器タイプ別

  • 心臓
  • 腎臓
  • 肝臓
  • 膵臓

第8章 固形臓器移植の拒絶反応市場拒否タイプ別

  • 急性拒絶反応
  • 慢性的な拒絶反応
  • 超急性拒絶反応

第9章 固形臓器移植の拒絶反応市場:エンドユーザー別

  • 病院
  • 専門クリニック

第10章 南北アメリカの固形臓器移植の拒絶反応市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域の固形臓器移植の拒絶反応市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカの固形臓器移植の拒絶反応市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • 先駆的なパートナーシップが臓器移植拒絶反応予防の画期的進歩を目指す
    • 移植後モニタリングの新開発:リアルタイム電子臓器健康トラッカー
    • GenDx、肺移植モニタリング強化のためトリノ大学からcfDNAアッセイのライセンシングを取得
  • 戦略分析と提言

第14章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET RESEARCH PROCESS
  • FIGURE 2. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SOLID ORGAN TRANSPLANTATION REJECTION MARKET DYNAMICS
  • FIGURE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. SOLID ORGAN TRANSPLANTATION REJECTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. SOLID ORGAN TRANSPLANTATION REJECTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BIOPSY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BIOPSY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BLOOD TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY BLOOD TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY IMAGING TESTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY IMAGING TESTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIBODIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ANTIMETABOLITES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STEROIDS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STEROIDS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HEART, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HEART, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY KIDNEYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY KIDNEYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LIVER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LIVER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LUNGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY LUNGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY PANCREAS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY PANCREAS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ACUTE REJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ACUTE REJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CHRONIC REJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY CHRONIC REJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HYPERACUTE REJECTION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HYPERACUTE REJECTION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 84. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 96. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 108. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 120. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 148. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 160. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 172. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 184. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 196. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 208. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 220. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 232. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 244. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 256. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 268. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 280. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY DIAGNOSIS & TESTING SOLUTIONS, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY MEDICATIONS, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY ORGAN TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY REJECTION TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM SOLID ORGAN TRANSPLANTATION REJECTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLIO
目次
Product Code: MRR-CB04E05661AD

[181 Pages Report] The Solid Organ Transplantation Rejection Market size was estimated at USD 7.79 billion in 2023 and expected to reach USD 8.15 billion in 2024, at a CAGR 4.90% to reach USD 10.89 billion by 2030.

Solid organ transplantation, encompassing the replacement of vital organs, including the lungs, heart, kidneys, or liver, markedly improves patient survival and quality of life. Solid organ transplantation rejection is a process in which a recipient's immune system identifies the transplanted organ as foreign and causes damage to the transplanted organ, creating the need for solid organ transplantation rejection medications and therapies. There is a rising number of individuals worldwide who suffer from organ failures, primarily due to chronic diseases, aging, and lifestyle factors. As the demand for organ transplants increases, the requirement for effective rejection management solutions also increases. This rise in organ transplantation propels the market growth. In addition, the rising public and professional awareness of advancements in solid organ transplantation and improved rejection management techniques significantly contribute to market growth. However, solid organ transplantation involves complex and costly medical procedures, including pre-transplant screenings, the surgery itself, post-operative care, and ongoing immunosuppression treatments, which require high costs and can be a significant barrier to market growth, as they may limit transplantation's accessibility for patients and strain healthcare budgets, particularly in less economically developed regions. The ongoing development of refined immunosuppressive treatments offers the opportunity for market expansion by reducing the incidence of organ rejection post-transplant.

KEY MARKET STATISTICS
Base Year [2023] USD 7.79 billion
Estimated Year [2024] USD 8.15 billion
Forecast Year [2030] USD 10.89 billion
CAGR (%) 4.90%

Regional Insights

In the Americas, particularly the United States, there is a high prevalence of organ transplants due to advanced medical facilities and a well-structured healthcare system. This region has a robust organ transplantation network and showcases a significant number of transplant procedures, leading to a substantial need for anti-rejection drugs and therapies. These products are essential to help in reducing the immune response against transplanted organs. The U.S. also leads in adopting new and advanced therapies due to strong regulatory support and substantial healthcare spending. The Asia-Pacific region is showcasing growth in the solid organ transplant rejection market, propelled by increasing healthcare infrastructure, rising medical tourism due to lower treatment costs, and growing awareness about transplantation as a viable option for chronic diseases. Countries, including India and China are seeing increased numbers of transplantations. The market for solid organ transplant rejection interventions in the EMEA region showcases significant growth due to increasing organ transplant procedures and heightened awareness about transplant rejection. Europe has well-established healthcare systems and supportive regulatory frameworks. The Middle East and Africa are witnessing gradual growth, influenced by improving healthcare infrastructure and international collaborations for transplant programs.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Solid Organ Transplantation Rejection Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing number of organ transplants worldwide
      • Rising awareness about the advancements in transplantation and rejection management
    • Market Restraints
      • High costs associated with transplantation procedures
    • Market Opportunities
      • Advancements in immunosuppressive treatments and monitoring technologies
      • Emergence of genetic testing to improve predicting rejection risks accurately
    • Market Challenges
      • Complexities associated with immunosuppressive therapies
  • Market Segmentation Analysis
    • Offering: Increasing need for medication to treat the rejection of the transplanted organ
    • End-User: Extensive use in hospitals for managing solid organ transplantation rejection
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Solid Organ Transplantation Rejection Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Solid Organ Transplantation Rejection Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Pioneering Partnership Targets Breakthrough in Organ Transplant Rejection Prevention

Taiwan Bio and TRACT Therapeutics collaborated on cutting-edge cellular therapy aimed at transforming the prevention of allograft rejection in solid organ transplants. This new alliance enhanced a Phase 2 clinical trial across multiple centers in the U.S. and Taiwan, focusing on decreasing the reliance on immunosuppressant drugs in recipients of kidney transplants from living donors. Combining Taiwan Bio's expertise in cellular therapy manufacturing with TRACT Therapeutics' innovative regulatory T-cell therapy platform, this partnership aims to significantly enhance transplant outcomes while improving patients' quality of life. [Published On: 2023-12-06]

New Development in Post-Transplant Monitoring: Real-Time Electronic Organ Health Tracker

Researchers at Northwestern University innovated the first electronic device designed for continuous, real-time health monitoring of transplanted organs. This study introduces a novel, ultrathin sensor that sits atop transplanted kidneys to monitor for temperature anomalies indicative of inflammation or other complications, which could signal rejection. The device enhances patient safety by wirelessly transmitting data directly to healthcare providers via smartphone or tablet, ensuring immediate medical response to potential issues. [Published On: 2023-09-08]

GenDx Acquires Licensing for cfDNA Assay from Torino University to Enhance Lung Transplant Monitoring

GenDx, a Dutch company, has obtained exclusive licensing rights for a cell-free DNA (cfDNA) assay from Torino University. This innovative diagnostic tool is specifically designed to detect and monitor organ rejection in lung transplant recipients. The cfDNA assay offers a non-invasive method to identify early signs of rejection, which is crucial for the timely intervention and management of transplant patients. This advancement promises to enhance post-transplant care by facilitating continuous monitoring and potentially improving patient outcomes. [Published On: 2023-05-25]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Solid Organ Transplantation Rejection Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Solid Organ Transplantation Rejection Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Accord Healthcare Limited, Asahi Kasei Corporation, Astellas Pharma Inc., Biocon, Cipla Ltd., Dr. Reddy's Laboratories Ltd., Eris Lifesciences Ltd., Eurofins Transplant Diagnostics, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Globela Pharma, Lupin Limited, Manus Aktteva Biopharma LLP, Natco Pharma Ltd., Novartis AG, Panacea Biotec Pharma Ltd., Pfizer Inc., Plexision, Sanofi S.A., SAS Alsachim by Shimadzu Group, Strides Pharma Global Pte Ltd., Teva Pharmaceuticals Inc., Thermo Fisher Scientific Inc., Veloxis Pharmaceuticals A/S, and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Solid Organ Transplantation Rejection Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Diagnosis & Testing Solutions
      • Biopsy
      • Blood Tests
      • Imaging Tests
    • Medications
      • Antibodies
      • Antimetabolites
      • Calcineurin Inhibitors
      • Steroids
  • Organ Type
    • Heart
    • Kidneys
    • Liver
    • Lungs
    • Pancreas
  • Rejection Type
    • Acute Rejection
    • Chronic Rejection
    • Hyperacute Rejection
  • End-User
    • Hospitals
    • Specialty Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing number of organ transplants worldwide
      • 5.1.1.2. Rising awareness about the advancements in transplantation and rejection management
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with transplantation procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in immunosuppressive treatments and monitoring technologies
      • 5.1.3.2. Emergence of genetic testing to improve predicting rejection risks accurately
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with immunosuppressive therapies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering: Increasing need for medication to treat the rejection of the transplanted organ
    • 5.2.2. End-User: Extensive use in hospitals for managing solid organ transplantation rejection
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Solid Organ Transplantation Rejection Market, by Offering

  • 6.1. Introduction
  • 6.2. Diagnosis & Testing Solutions
  • 6.3. Medications

7. Solid Organ Transplantation Rejection Market, by Organ Type

  • 7.1. Introduction
  • 7.2. Heart
  • 7.3. Kidneys
  • 7.4. Liver
  • 7.5. Lungs
  • 7.6. Pancreas

8. Solid Organ Transplantation Rejection Market, by Rejection Type

  • 8.1. Introduction
  • 8.2. Acute Rejection
  • 8.3. Chronic Rejection
  • 8.4. Hyperacute Rejection

9. Solid Organ Transplantation Rejection Market, by End-User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Specialty Clinics

10. Americas Solid Organ Transplantation Rejection Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Solid Organ Transplantation Rejection Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Solid Organ Transplantation Rejection Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Pioneering Partnership Targets Breakthrough in Organ Transplant Rejection Prevention
    • 13.3.2. New Development in Post-Transplant Monitoring: Real-Time Electronic Organ Health Tracker
    • 13.3.3. GenDx Acquires Licensing for cfDNA Assay from Torino University to Enhance Lung Transplant Monitoring
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio